Benefits and Risks of Hormonal Contraception - Has the Attitude Changed? - The Proceedings of an International Symposium, Amsterdam, 19th March, 1982

Haspels, A. A. (edited); Rolland, R (edited)

ISBN 10: 0852004575 / ISBN 13: 9780852004579

Published by MTP Press Limited, Lancaster, England, 1982

About this Item

First Edition / First Print. Hardback copy in burgundy cloth boards with gold gilt lettering to spine. Unclipped dustjacket in new removable protective clear sleeve. 192pp. B/w diagrams and graphs throughout. Not library copy, presentation bookplate to ffep. (31/1).

Seller Inventory # ABE-1690904750226

Bibliographic Details

• Title: Benefits and Risks of Hormonal Contraception - Has the Attitude Changed? - The Proceedings of an International Symposium, Amsterdam, 19th March, 1982
• Publisher: MTP Press Limited, Lancaster, England
• Publication Date: 1982
• Language: English
• ISBN 10: 0852004575
• ISBN 13: 9780852004579
• Binding: Hardcover
• Edition: 1st Edition
• Condition: Very Good
• Dust Jacket Condition: Very Good

About this title

Synopsis

A. A. Haspe/s It is with pleasure that I welcome you, on behalf of Professor Rolland and myself, to Amsterdam for this International Symposium on 'Benefits and Risks of Hormonal Contraception'. As a means offamily planning the pill is about 25 years old - a timespan which has been characterized by an enormous increase in public interest and concern with family health and family-planning. Undoubtedly we have learned a lot over the last 25 years. As you see in Figure 1, in the seventies in Holland relatively more fertile women used the pill than in any other country in the world. In 1974 new combination pills were introduced containing less than 50 JAg of ethinyl estradiol. In 1981 50 % of Dutch pill­ users took a sub-50 (Figure 2). The same is true for the Scandi­ navian countries. In our own University Clinic 95 % of pill-users take a sub-50 pill; only 5 % use a 50 JAg pill on medical indication. This decrease in estrogen dosage, which is usually accompanied by a decrease of progestational component as well, has resulted in a decrease of thromboembolic disease. Factors that are still important to consider are diabetes mellitus, hypertension, adipositas and smoking. Good selection of patients together with the prescribing where possible of sub-50 pills may result in the numbers of compli­ cations and side-effects being close to those encountered in the control group.